Phibro Animal Health | PAHC - Selling And Administration Expenses


Phibro Animal Health reported $78.32M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Align Technology USD 441.68M 23.88M Dec/2025
ANI Pharmaceuticals USD 82.79M 6.13M Dec/2025
Assertio Holdings USD 16.73M 1.66M Sep/2024
Aurora Cannabis CAD 40.62M 1.17M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Canopy Growth CAD 28.9M 636K Dec/2025
Corcept Therapeutics USD 114.74M 7.77M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Merck USD 2.85B 215M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 91.87M 70K Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 29.67M 1.64M Dec/2025
Supernus Pharmaceuticals USD 122.39M 57.29M Dec/2025
Zoetis USD 619M 40M Dec/2025